Financials data is unavailable for this security.
View more
Year on year Clearpoint Neuro Inc had net income fall 34.40% from a loss of 16.44m to a larger loss of 22.09m despite a 16.56% increase in revenues from 20.55m to 23.96m. An increase in the selling, general and administrative costs as a percentage of sales from 92.30% to 101.65% was a component in the falling net income despite rising revenues.
| Gross margin | 60.38% |
|---|---|
| Net profit margin | -59.64% |
| Operating margin | -61.94% |
| Return on assets | -43.19% |
|---|---|
| Return on equity | -68.36% |
| Return on investment | -51.20% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Clearpoint Neuro Inc fell by 4.48m. However, Cash Flow from Investing totalled 8.95m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 13.72m for operations while cash generated from financing totalled 296.00k.
| Cash flow per share | -0.6553 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.05 |
|---|---|
| Tangible book value per share | 1.03 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.54 |
|---|---|
| Quick ratio | 3.61 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
